1. de Lange, Katrina M, Moutsianas, Loukas, Lee, James C, Anderson, Carl A, Barrett, Jeffrey C. 2017. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. In Nature genetics, 49, 256-261. doi:10.1038/ng.3760. https://pubmed.ncbi.nlm.nih.gov/28067908/
2. Wu, Dan, Zhang, Pinglu, Ma, Ji, Chen, Meifen, Xu, Hongtao. 2019. Serum biomarker panels for the diagnosis of gastric cancer. In Cancer medicine, 8, 1576-1583. doi:10.1002/cam4.2055. https://pubmed.ncbi.nlm.nih.gov/30873760/
3. Teng, Lisha, Shen, Lingling, Zhao, Wenjun, Chen, Jianghua, Jiang, Hong. 2022. SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages. In Frontiers in immunology, 13, 846695. doi:10.3389/fimmu.2022.846695. https://pubmed.ncbi.nlm.nih.gov/35432371/
4. Zheng, Yuli, Wang, Liudi, Zhao, Yan, Qi, Yao, Qi, Le. 2023. Upregulation of SLAMF8 aggravates ischemia/reperfusion-induced ferroptosis and injury in cardiomyocyte. In International journal of cardiology, 399, 131688. doi:10.1016/j.ijcard.2023.131688. https://pubmed.ncbi.nlm.nih.gov/38158136/
5. Wang, Yibo, Hang, Kai, Wu, Xiaoyong, Pan, Zhijun, Zou, Xuenong. 2024. SLAMF8 regulates osteogenesis and adipogenesis of bone marrow mesenchymal stem cells via S100A6/Wnt/β-catenin signaling pathway. In Stem cell research & therapy, 15, 349. doi:10.1186/s13287-024-03964-1. https://pubmed.ncbi.nlm.nih.gov/39380096/
6. Li, Guangyao, Li, Qijiao, Ping, Miaomiao, Guo, Jizheng, Cheng, Ya. 2024. SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer. In Aging, 16, 8944-8964. doi:10.18632/aging.205850. https://pubmed.ncbi.nlm.nih.gov/38787377/
智鼠故事 
